|
· Kandpal R.P. (2006) Rho GTPase activating proteins in cancer cells. Curr Prot Pept Sci. 7,355-65
· Alsaber, R., Tabone, C.J., and Kandpal, R.P. (2006) Predicting candidate genes for human deafness disorders: a bioinformatics approach. BMC Genomics, 7, 180.
· Fox, B.P., Tabone, C.J., and Kandpal, R.P. (2006) Potential Clinical Relevance of Eph Receptors and Ephrin Ligands Expressed in Prostate Carcinoma Cell Lines. Biochem Biophys Res Comm. 342, 1263-72.
· Nagaraja, G.M., Othman, M., Fox, B.P., Alsaber, R., Pelegrino, C.M., Zeng, Y., Khanna, R., Tamburini, P., Swaroop, A. and Kandpal, R.P. (2005) Gene expression signatures and molecular biomarkers of noninvasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 25, 2328-2338.
· Fox, BP and Kandpal, R.P. (2006). Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR. Biochem Biophys Res Comm 340, 268-276
· Nagaraja, G.M. and Kandpal, R.P. (2004) Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. Biochem Biophys Res Comm 313, 654-665.
· Fox, B.P. and Kandpal, R.P. (2004) Invasiveness of breast carcinoma cells and transcript profiles: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem Biophys Res Comm 318, 882-892.
· Kalapurakal, J., Jacob, A.N.K., Y., Najjar, D., Hsich, Y.C., Harkaway, R., Ginsberg, P., Daskal, I., Asbell, S.O. and Kandpal, R.P. (1999) Racial differences in prostate cancer as related to loss of heterozygosity (LOH) at chromosome 8p12-23. International J Rad Onc Biol Phys. 45,835-840.
· Jacob, A.N.K., Kalapurakal, J., Davidson, W., Kandpal, G., Dunson, N., Prashar, Y. and Kandpal, R.P. (1999) A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145. Cancer Detection and Prevention, 23. 325-332.
|